Literature DB >> 22688065

Epidemiological features of moyamoya disease in Japan.

Haruhiko Hoshino1, Yoshikane Izawa, Norihiro Suzuki.   

Abstract

To clarify the clinical features of moyamoya disease in Japan, 941 patients with definite moyamoya disease were analyzed from the databases constructed by the Research Committee on Moyamoya Disease, established by the Ministry of Health, Labour and Welfare. Moyamoya disease occurs much more frequently among women than men, with a female-to-male ratio of 1.98. A family history of the disease was observed in 14.9%. The age at onset was characterized by two peaks: one at 5-9 years and another lower peak at around 40 years. Initial clinical features were transient ischemic attack in 46%, infarction in 20%, hemorrhage in 21%, headache in 6%, and epilepsy in 4%. The distribution of the age at onset showed one peak at around 40 years in patients with hemorrhage but two peaks in patients with ischemia.

Entities:  

Mesh:

Year:  2012        PMID: 22688065     DOI: 10.2176/nmc.52.295

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  14 in total

1.  Moyamoya syndrome associated with Graves' disease: a case series study.

Authors:  Jun Ni; Li-Xin Zhou; Yan-Ping Wei; Ming-Li Li; Wei-Hai Xu; Shan Gao; Li-Ying Cui
Journal:  Ann Transl Med       Date:  2014-08

2.  Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.

Authors:  Yang Cao; Hatasu Kobayashi; Takaaki Morimoto; Risako Kabata; Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2016-06-30       Impact factor: 3.674

3.  Moyamoya disease in pregnancy and delivery planning: A case series and literature review.

Authors:  Erica Weston; Niharika Mehta
Journal:  Obstet Med       Date:  2016-07-28

4.  Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institution.

Authors:  Güliz Acker; Marcus Czabanka; Peter Schmiedek; Peter Vajkoczy
Journal:  Neurosurg Rev       Date:  2017-09-18       Impact factor: 3.042

Review 5.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

6.  Ivy Sign on Fluid-Attenuated Inversion Recovery Images in Moyamoya Disease: Correlation with Clinical Severity and Old Brain Lesions.

Authors:  Kwon-Duk Seo; Sang Hyun Suh; Yong Bae Kim; Ji Hwa Kim; Sung Jun Ahn; Dong-Seok Kim; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

Review 7.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

Review 8.  Role of Ring Finger Protein 213 in Moyamoya Disease.

Authors:  Yong-Gang Ma; Qian Zhang; Le-Bao Yu; Ji-Zong Zhao
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

9.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

10.  Moyamoya Vasculopathy in Indian Children: Our Experience.

Authors:  Varsha Anant Patil; Shilpa Dattaprasanna Kulkarni; Chandrashekhar E Deopujari; Naresh K Biyani; Anaita H Udwadia-Hegde; Krishnakumar N Shah
Journal:  J Pediatr Neurosci       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.